GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HEL4, a soluble human vh antibody domain resistant to aggregation

Analyse Crystal structure of HEL4, a soluble human vh antibody domain resistant to… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1OHQ
Type
protein
Length
239 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Immunoglobulin
Pockets
3 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AImmunoglobulinprotein1205% helix, 51% strand—
BImmunoglobulinprotein1195% helix, 55% strand—

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1900.610.8927empty
2810.310.7314empty
3530.270.7315empty

Interfaces

1 interface between chains.

  • A–B · 970 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 1OHQ · Crystal structure of HEL4, a soluble human VH antibody domain resistant to aggregation · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.